We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
-$692M
Cap. Flow %
-0.42%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,245
Increased
2,719
Reduced
2,446
Closed
981

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$643M
2
T icon
AT&T
T
+$311M
3
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$306M
4
MSFT icon
Microsoft
MSFT
+$292M
5
AME icon
Ametek
AME
+$215M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$887M
2
AAPL icon
Apple
AAPL
+$694M
3
PRAH
PRA Health Sciences, Inc.
PRAH
+$616M
4
AMZN icon
Amazon
AMZN
+$596M
5
LIN icon
Linde
LIN
+$531M

Sector Composition

Rank Sector Weight
1 Miscellaneous 58.05%
2 Technology 7.69%
3 Financials 6.83%
4 Healthcare 6.42%
5 Industrials 4.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORMP icon
4176
Oramed Pharmaceuticals
ORMP
$209M
$1.52M ﹤0.01%
69,186
-132,034
-66% -$2.25M
INDIW
4177
CALL
DELISTED
indie Semiconductor, Inc. Warrant
INDIW
$1.52M ﹤0.01%
429,600
+325,000
+311% +$759K
AHRT
4178
AH Realty Trust
AHRT
$488M
$1.52M ﹤0.01%
+113,629
New +$1.5M
GRFS
4179
CALL
Grifois
GRFS
$5.23B
$1.52M ﹤0.01%
+103,900
New +$1.57M
HCICU
4180
DELISTED
Hennessy Capital Investment Corp. V Units
HCICU
$1.52M ﹤0.01%
149,123
-26,068
-15% -$269K
RNAC icon
4181
Cartesian Therapeutics
RNAC
$290M
$1.51M ﹤0.01%
12,143
-30,022
-71% -$3.63M
DRH icon
4182
Diamondrock Hospitality Co
DRH
$2.6B
$1.51M ﹤0.01%
159,896
-37,598
-19% -$336K
UHT
4183
Universal Health Realty Income Trust
UHT
$576M
$1.51M ﹤0.01%
27,331
-2,838
-9% -$167K
FA icon
4184
First Advantage
FA
$3.61B
$1.51M ﹤0.01%
79,276
-32,649
-29% -$686K
APTO
4185
DELISTED
Aptose Biosciences, Inc.
APTO
$1.51M ﹤0.01%
1,539
+838
+120% +$1.05M
RSVR
4186
Reservoir Media
RSVR
$637M
$1.51M ﹤0.01%
165,588
-367,058
-69% -$3.22M
CENQU
4187
DELISTED
CENAQ Energy Corp. Unit
CENQU
$1.51M ﹤0.01%
+150,000
New +$1.5M
SAFM
4188
CALL
DELISTED
Sanderson Farms Inc
SAFM
$1.51M ﹤0.01%
+8,000
New +$1.51M
PSQH icon
4189
PSQ Holdings
PSQH
$22.3M
$1.5M ﹤0.01%
+10,367
New +$1.5M
ISTR icon
4190
Investar Holding Corp
ISTR
$417M
$1.5M ﹤0.01%
68,273
-67,771
-50% -$1.51M
KGC icon
4191
PUT
Kinross Gold
KGC
$37.1B
$1.5M ﹤0.01%
280,000
– –
GAP
4192
The Gap Inc
GAP
$8.45B
$1.5M ﹤0.01%
66,109
-25,627
-28% -$708K
MSM icon
4193
MSC Industrial Direct
MSM
$6.66B
$1.5M ﹤0.01%
18,702
+9,736
+109% +$827K
OPEN icon
4194
Opendoor
OPEN
$3.19B
$1.5M ﹤0.01%
75,478
-445,455
-86% -$7.2M
DNA.WS
4195
CALL
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$1.5M ﹤0.01%
+442,015
New +$1.57M
FBRX icon
4196
Forte Biosciences
FBRX
$1.5M ﹤0.01%
20,210
+19,447
+2,549% +$10.8M
AIFU
4197
AIFU Inc
AIFU
$127M
$1.5M ﹤0.01%
311
+247
+386% +$1.38M
SCOAU
4198
DELISTED
ScION Tech Growth I Unit
SCOAU
$1.5M ﹤0.01%
150,002
-4
-0% -$40
INSW icon
4199
International Seaways
INSW
$4.89B
$1.49M ﹤0.01%
+81,863
New +$1.4M
OPT
4200
DELISTED
Opthea Limited American Depositary Shares
OPT
$1.49M ﹤0.01%
186,179
-8,155
-4% -$61.9K
166 167
168
169 170

Similar funds

AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM

Israel Englander's Q3 2021 Portfolio in Review

As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.

By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.

  • Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
  • Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.